Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Treatment of plaque psoriasis by a topical plasminogen binding inhibitor, EP0003
| Reference number | 2017-01400 |
| Coordinator | Emeriti Pharma AB |
| Funding from Vinnova | SEK 0 |
| Project duration | June 2017 - December 2018 |
| Status | Completed |
| Venture | Swelife and Medtech4Health- Project proposals to improve health |
